Cargando…
Erythrodermic psoriasis: pathophysiology and current treatment perspectives
Erythrodermic psoriasis (EP) is a rare and severe variant of psoriasis vulgaris, with an estimated prevalence of 1%–2.25% among psoriatic patients. The condition presents with distinct histopathologic and clinical findings, which include a generalized inflammatory erythema involving at least 75% of...
Autores principales: | Singh, Rasnik K, Lee, Kristina M, Ucmak, Derya, Brodsky, Merrick, Atanelov, Zaza, Farahnik, Benjamin, Abrouk, Michael, Nakamura, Mio, Zhu, Tian Hao, Liao, Wilson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572467/ https://www.ncbi.nlm.nih.gov/pubmed/28856115 http://dx.doi.org/10.2147/PTT.S101232 |
Ejemplares similares
-
The Patient’s Guide to Psoriasis Treatment. Part 1: UVB Phototherapy
por: Singh, Rasnik K., et al.
Publicado: (2016) -
Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule()
por: Abrouk, Michael, et al.
Publicado: (2016) -
The Patient’s Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy
por: Zhu, Tian Hao, et al.
Publicado: (2016) -
Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials
por: Farahnik, Benjamin, et al.
Publicado: (2016) -
Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials
por: Farahnik, Benjamin, et al.
Publicado: (2016)